ArticleCancer research2015

Genetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10.

Joshua E Allen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.